nodes	percent_of_prediction	percent_of_DWPC	metapath
Ceftaroline fosamil—Phlebitis—Dactinomycin—muscle cancer	0.0251	0.0251	CcSEcCtD
Ceftaroline fosamil—Transaminases increased—Doxorubicin—muscle cancer	0.0184	0.0184	CcSEcCtD
Ceftaroline fosamil—Phlebitis—Etoposide—muscle cancer	0.0182	0.0182	CcSEcCtD
Ceftaroline fosamil—Neutropenia—Dactinomycin—muscle cancer	0.0175	0.0175	CcSEcCtD
Ceftaroline fosamil—Neutropenia—Vincristine—muscle cancer	0.0156	0.0156	CcSEcCtD
Ceftaroline fosamil—Hepatitis—Dactinomycin—muscle cancer	0.015	0.015	CcSEcCtD
Ceftaroline fosamil—Urinary tract disorder—Vincristine—muscle cancer	0.0132	0.0132	CcSEcCtD
Ceftaroline fosamil—Urethral disorder—Vincristine—muscle cancer	0.0131	0.0131	CcSEcCtD
Ceftaroline fosamil—Erythema—Dactinomycin—muscle cancer	0.013	0.013	CcSEcCtD
Ceftaroline fosamil—Neutropenia—Etoposide—muscle cancer	0.0126	0.0126	CcSEcCtD
Ceftaroline fosamil—Angiopathy—Vincristine—muscle cancer	0.0121	0.0121	CcSEcCtD
Ceftaroline fosamil—Infestation NOS—Etoposide—muscle cancer	0.0121	0.0121	CcSEcCtD
Ceftaroline fosamil—Infestation—Etoposide—muscle cancer	0.0121	0.0121	CcSEcCtD
Ceftaroline fosamil—Anaemia—Dactinomycin—muscle cancer	0.012	0.012	CcSEcCtD
Ceftaroline fosamil—Renal failure—Etoposide—muscle cancer	0.0119	0.0119	CcSEcCtD
Ceftaroline fosamil—Hepatobiliary disease—Etoposide—muscle cancer	0.0114	0.0114	CcSEcCtD
Ceftaroline fosamil—Hyperkalaemia—Doxorubicin—muscle cancer	0.011	0.011	CcSEcCtD
Ceftaroline fosamil—Anaemia—Vincristine—muscle cancer	0.0108	0.0108	CcSEcCtD
Ceftaroline fosamil—Urinary tract disorder—Etoposide—muscle cancer	0.0107	0.0107	CcSEcCtD
Ceftaroline fosamil—Urethral disorder—Etoposide—muscle cancer	0.0106	0.0106	CcSEcCtD
Ceftaroline fosamil—Thrombocytopenia—Dactinomycin—muscle cancer	0.0104	0.0104	CcSEcCtD
Ceftaroline fosamil—Convulsion—Vincristine—muscle cancer	0.0101	0.0101	CcSEcCtD
Ceftaroline fosamil—Angiopathy—Etoposide—muscle cancer	0.00982	0.00982	CcSEcCtD
Ceftaroline fosamil—Immune system disorder—Etoposide—muscle cancer	0.00978	0.00978	CcSEcCtD
Ceftaroline fosamil—Anaphylactic shock—Vincristine—muscle cancer	0.0095	0.0095	CcSEcCtD
Ceftaroline fosamil—Phlebitis—Doxorubicin—muscle cancer	0.00942	0.00942	CcSEcCtD
Ceftaroline fosamil—Nervous system disorder—Vincristine—muscle cancer	0.00931	0.00931	CcSEcCtD
Ceftaroline fosamil—Thrombocytopenia—Vincristine—muscle cancer	0.0093	0.0093	CcSEcCtD
Ceftaroline fosamil—Pain—Dactinomycin—muscle cancer	0.00909	0.00909	CcSEcCtD
Ceftaroline fosamil—Anaemia—Etoposide—muscle cancer	0.00871	0.00871	CcSEcCtD
Ceftaroline fosamil—Gastrointestinal pain—Dactinomycin—muscle cancer	0.00869	0.00869	CcSEcCtD
Ceftaroline fosamil—Abdominal pain—Dactinomycin—muscle cancer	0.0084	0.0084	CcSEcCtD
Ceftaroline fosamil—Body temperature increased—Dactinomycin—muscle cancer	0.0084	0.0084	CcSEcCtD
Ceftaroline fosamil—Gastrointestinal disorder—Vincristine—muscle cancer	0.0082	0.0082	CcSEcCtD
Ceftaroline fosamil—Convulsion—Etoposide—muscle cancer	0.00817	0.00817	CcSEcCtD
Ceftaroline fosamil—Constipation—Vincristine—muscle cancer	0.00812	0.00812	CcSEcCtD
Ceftaroline fosamil—Pain—Vincristine—muscle cancer	0.00812	0.00812	CcSEcCtD
Ceftaroline fosamil—Eosinophilia—Methotrexate—muscle cancer	0.00802	0.00802	CcSEcCtD
Ceftaroline fosamil—Unspecified disorder of skin and subcutaneous tissue—Etoposide—muscle cancer	0.00797	0.00797	CcSEcCtD
Ceftaroline fosamil—Hypersensitivity—Dactinomycin—muscle cancer	0.00783	0.00783	CcSEcCtD
Ceftaroline fosamil—Gastrointestinal pain—Vincristine—muscle cancer	0.00776	0.00776	CcSEcCtD
Ceftaroline fosamil—Anaphylactic shock—Etoposide—muscle cancer	0.00769	0.00769	CcSEcCtD
Ceftaroline fosamil—Neutropenia—Methotrexate—muscle cancer	0.00758	0.00758	CcSEcCtD
Ceftaroline fosamil—Thrombocytopenia—Etoposide—muscle cancer	0.00753	0.00753	CcSEcCtD
Ceftaroline fosamil—Abdominal pain—Vincristine—muscle cancer	0.00751	0.00751	CcSEcCtD
Ceftaroline fosamil—Body temperature increased—Vincristine—muscle cancer	0.00751	0.00751	CcSEcCtD
Ceftaroline fosamil—Skin disorder—Etoposide—muscle cancer	0.00747	0.00747	CcSEcCtD
Ceftaroline fosamil—Hypokalaemia—Doxorubicin—muscle cancer	0.00739	0.00739	CcSEcCtD
Ceftaroline fosamil—Diarrhoea—Dactinomycin—muscle cancer	0.00727	0.00727	CcSEcCtD
Ceftaroline fosamil—Infestation NOS—Methotrexate—muscle cancer	0.00722	0.00722	CcSEcCtD
Ceftaroline fosamil—Infestation—Methotrexate—muscle cancer	0.00722	0.00722	CcSEcCtD
Ceftaroline fosamil—Renal failure—Methotrexate—muscle cancer	0.0071	0.0071	CcSEcCtD
Ceftaroline fosamil—Hypersensitivity—Vincristine—muscle cancer	0.007	0.007	CcSEcCtD
Ceftaroline fosamil—Eosinophilia—Doxorubicin—muscle cancer	0.00695	0.00695	CcSEcCtD
Ceftaroline fosamil—Hepatobiliary disease—Methotrexate—muscle cancer	0.00683	0.00683	CcSEcCtD
Ceftaroline fosamil—Vomiting—Dactinomycin—muscle cancer	0.00676	0.00676	CcSEcCtD
Ceftaroline fosamil—Rash—Dactinomycin—muscle cancer	0.0067	0.0067	CcSEcCtD
Ceftaroline fosamil—Gastrointestinal disorder—Etoposide—muscle cancer	0.00664	0.00664	CcSEcCtD
Ceftaroline fosamil—Pain—Etoposide—muscle cancer	0.00658	0.00658	CcSEcCtD
Ceftaroline fosamil—Constipation—Etoposide—muscle cancer	0.00658	0.00658	CcSEcCtD
Ceftaroline fosamil—Neutropenia—Doxorubicin—muscle cancer	0.00656	0.00656	CcSEcCtD
Ceftaroline fosamil—Diarrhoea—Vincristine—muscle cancer	0.0065	0.0065	CcSEcCtD
Ceftaroline fosamil—Hepatitis—Methotrexate—muscle cancer	0.00649	0.00649	CcSEcCtD
Ceftaroline fosamil—Urinary tract disorder—Methotrexate—muscle cancer	0.0064	0.0064	CcSEcCtD
Ceftaroline fosamil—Urethral disorder—Methotrexate—muscle cancer	0.00636	0.00636	CcSEcCtD
Ceftaroline fosamil—Hyperglycaemia—Doxorubicin—muscle cancer	0.00633	0.00633	CcSEcCtD
Ceftaroline fosamil—Nausea—Dactinomycin—muscle cancer	0.00631	0.00631	CcSEcCtD
Ceftaroline fosamil—Gastrointestinal pain—Etoposide—muscle cancer	0.00629	0.00629	CcSEcCtD
Ceftaroline fosamil—Dizziness—Vincristine—muscle cancer	0.00628	0.00628	CcSEcCtD
Ceftaroline fosamil—Infestation—Doxorubicin—muscle cancer	0.00626	0.00626	CcSEcCtD
Ceftaroline fosamil—Infestation NOS—Doxorubicin—muscle cancer	0.00626	0.00626	CcSEcCtD
Ceftaroline fosamil—Renal failure—Doxorubicin—muscle cancer	0.00615	0.00615	CcSEcCtD
Ceftaroline fosamil—Urticaria—Etoposide—muscle cancer	0.00611	0.00611	CcSEcCtD
Ceftaroline fosamil—Body temperature increased—Etoposide—muscle cancer	0.00608	0.00608	CcSEcCtD
Ceftaroline fosamil—Abdominal pain—Etoposide—muscle cancer	0.00608	0.00608	CcSEcCtD
Ceftaroline fosamil—Vomiting—Vincristine—muscle cancer	0.00604	0.00604	CcSEcCtD
Ceftaroline fosamil—Rash—Vincristine—muscle cancer	0.00599	0.00599	CcSEcCtD
Ceftaroline fosamil—Dermatitis—Vincristine—muscle cancer	0.00598	0.00598	CcSEcCtD
Ceftaroline fosamil—Headache—Vincristine—muscle cancer	0.00595	0.00595	CcSEcCtD
Ceftaroline fosamil—Hepatobiliary disease—Doxorubicin—muscle cancer	0.00592	0.00592	CcSEcCtD
Ceftaroline fosamil—Angiopathy—Methotrexate—muscle cancer	0.00588	0.00588	CcSEcCtD
Ceftaroline fosamil—Immune system disorder—Methotrexate—muscle cancer	0.00586	0.00586	CcSEcCtD
Ceftaroline fosamil—Bradycardia—Doxorubicin—muscle cancer	0.00572	0.00572	CcSEcCtD
Ceftaroline fosamil—Hypersensitivity—Etoposide—muscle cancer	0.00567	0.00567	CcSEcCtD
Ceftaroline fosamil—Malnutrition—Methotrexate—muscle cancer	0.00565	0.00565	CcSEcCtD
Ceftaroline fosamil—Erythema—Methotrexate—muscle cancer	0.00565	0.00565	CcSEcCtD
Ceftaroline fosamil—Nausea—Vincristine—muscle cancer	0.00564	0.00564	CcSEcCtD
Ceftaroline fosamil—Hepatitis—Doxorubicin—muscle cancer	0.00562	0.00562	CcSEcCtD
Ceftaroline fosamil—Urinary tract disorder—Doxorubicin—muscle cancer	0.00555	0.00555	CcSEcCtD
Ceftaroline fosamil—Urethral disorder—Doxorubicin—muscle cancer	0.0055	0.0055	CcSEcCtD
Ceftaroline fosamil—Pruritus—Etoposide—muscle cancer	0.00544	0.00544	CcSEcCtD
Ceftaroline fosamil—Diarrhoea—Etoposide—muscle cancer	0.00526	0.00526	CcSEcCtD
Ceftaroline fosamil—Anaemia—Methotrexate—muscle cancer	0.00522	0.00522	CcSEcCtD
Ceftaroline fosamil—Angiopathy—Doxorubicin—muscle cancer	0.00509	0.00509	CcSEcCtD
Ceftaroline fosamil—Dizziness—Etoposide—muscle cancer	0.00509	0.00509	CcSEcCtD
Ceftaroline fosamil—Immune system disorder—Doxorubicin—muscle cancer	0.00507	0.00507	CcSEcCtD
Ceftaroline fosamil—Convulsion—Methotrexate—muscle cancer	0.00489	0.00489	CcSEcCtD
Ceftaroline fosamil—Vomiting—Etoposide—muscle cancer	0.00489	0.00489	CcSEcCtD
Ceftaroline fosamil—Malnutrition—Doxorubicin—muscle cancer	0.00489	0.00489	CcSEcCtD
Ceftaroline fosamil—Erythema—Doxorubicin—muscle cancer	0.00489	0.00489	CcSEcCtD
Ceftaroline fosamil—Rash—Etoposide—muscle cancer	0.00485	0.00485	CcSEcCtD
Ceftaroline fosamil—Dermatitis—Etoposide—muscle cancer	0.00485	0.00485	CcSEcCtD
Ceftaroline fosamil—Headache—Etoposide—muscle cancer	0.00482	0.00482	CcSEcCtD
Ceftaroline fosamil—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—muscle cancer	0.00477	0.00477	CcSEcCtD
Ceftaroline fosamil—Anaphylactic shock—Methotrexate—muscle cancer	0.00461	0.00461	CcSEcCtD
Ceftaroline fosamil—Nausea—Etoposide—muscle cancer	0.00457	0.00457	CcSEcCtD
Ceftaroline fosamil—Nervous system disorder—Methotrexate—muscle cancer	0.00452	0.00452	CcSEcCtD
Ceftaroline fosamil—Anaemia—Doxorubicin—muscle cancer	0.00452	0.00452	CcSEcCtD
Ceftaroline fosamil—Thrombocytopenia—Methotrexate—muscle cancer	0.00451	0.00451	CcSEcCtD
Ceftaroline fosamil—Skin disorder—Methotrexate—muscle cancer	0.00448	0.00448	CcSEcCtD
Ceftaroline fosamil—Palpitations—Doxorubicin—muscle cancer	0.00432	0.00432	CcSEcCtD
Ceftaroline fosamil—Convulsion—Doxorubicin—muscle cancer	0.00424	0.00424	CcSEcCtD
Ceftaroline fosamil—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—muscle cancer	0.00413	0.00413	CcSEcCtD
Ceftaroline fosamil—Anaphylactic shock—Doxorubicin—muscle cancer	0.00399	0.00399	CcSEcCtD
Ceftaroline fosamil—Gastrointestinal disorder—Methotrexate—muscle cancer	0.00398	0.00398	CcSEcCtD
Ceftaroline fosamil—Pain—Methotrexate—muscle cancer	0.00394	0.00394	CcSEcCtD
Ceftaroline fosamil—Nervous system disorder—Doxorubicin—muscle cancer	0.00391	0.00391	CcSEcCtD
Ceftaroline fosamil—Thrombocytopenia—Doxorubicin—muscle cancer	0.00391	0.00391	CcSEcCtD
Ceftaroline fosamil—Skin disorder—Doxorubicin—muscle cancer	0.00388	0.00388	CcSEcCtD
Ceftaroline fosamil—Gastrointestinal pain—Methotrexate—muscle cancer	0.00377	0.00377	CcSEcCtD
Ceftaroline fosamil—Urticaria—Methotrexate—muscle cancer	0.00366	0.00366	CcSEcCtD
Ceftaroline fosamil—Body temperature increased—Methotrexate—muscle cancer	0.00364	0.00364	CcSEcCtD
Ceftaroline fosamil—Abdominal pain—Methotrexate—muscle cancer	0.00364	0.00364	CcSEcCtD
Ceftaroline fosamil—Gastrointestinal disorder—Doxorubicin—muscle cancer	0.00344	0.00344	CcSEcCtD
Ceftaroline fosamil—Pain—Doxorubicin—muscle cancer	0.00341	0.00341	CcSEcCtD
Ceftaroline fosamil—Constipation—Doxorubicin—muscle cancer	0.00341	0.00341	CcSEcCtD
Ceftaroline fosamil—Hypersensitivity—Methotrexate—muscle cancer	0.00339	0.00339	CcSEcCtD
Ceftaroline fosamil—Gastrointestinal pain—Doxorubicin—muscle cancer	0.00326	0.00326	CcSEcCtD
Ceftaroline fosamil—Pruritus—Methotrexate—muscle cancer	0.00326	0.00326	CcSEcCtD
Ceftaroline fosamil—Urticaria—Doxorubicin—muscle cancer	0.00317	0.00317	CcSEcCtD
Ceftaroline fosamil—Abdominal pain—Doxorubicin—muscle cancer	0.00315	0.00315	CcSEcCtD
Ceftaroline fosamil—Body temperature increased—Doxorubicin—muscle cancer	0.00315	0.00315	CcSEcCtD
Ceftaroline fosamil—Diarrhoea—Methotrexate—muscle cancer	0.00315	0.00315	CcSEcCtD
Ceftaroline fosamil—Dizziness—Methotrexate—muscle cancer	0.00305	0.00305	CcSEcCtD
Ceftaroline fosamil—Hypersensitivity—Doxorubicin—muscle cancer	0.00294	0.00294	CcSEcCtD
Ceftaroline fosamil—Vomiting—Methotrexate—muscle cancer	0.00293	0.00293	CcSEcCtD
Ceftaroline fosamil—Rash—Methotrexate—muscle cancer	0.00291	0.00291	CcSEcCtD
Ceftaroline fosamil—Dermatitis—Methotrexate—muscle cancer	0.0029	0.0029	CcSEcCtD
Ceftaroline fosamil—Headache—Methotrexate—muscle cancer	0.00289	0.00289	CcSEcCtD
Ceftaroline fosamil—Pruritus—Doxorubicin—muscle cancer	0.00282	0.00282	CcSEcCtD
Ceftaroline fosamil—Nausea—Methotrexate—muscle cancer	0.00274	0.00274	CcSEcCtD
Ceftaroline fosamil—Diarrhoea—Doxorubicin—muscle cancer	0.00273	0.00273	CcSEcCtD
Ceftaroline fosamil—Dizziness—Doxorubicin—muscle cancer	0.00264	0.00264	CcSEcCtD
Ceftaroline fosamil—Vomiting—Doxorubicin—muscle cancer	0.00254	0.00254	CcSEcCtD
Ceftaroline fosamil—Rash—Doxorubicin—muscle cancer	0.00252	0.00252	CcSEcCtD
Ceftaroline fosamil—Dermatitis—Doxorubicin—muscle cancer	0.00251	0.00251	CcSEcCtD
Ceftaroline fosamil—Headache—Doxorubicin—muscle cancer	0.0025	0.0025	CcSEcCtD
Ceftaroline fosamil—Nausea—Doxorubicin—muscle cancer	0.00237	0.00237	CcSEcCtD
